1. |
|
2. |
20
Osterberg J, Ljungdahl M, Haglund U. Influence of cyclooxygenase inhibitors on gut immune cell distribution and apoptosis rate in experimental sepsis
[
J
]
. Shock
,
2006; 25(2)
∶
147.
|
3. |
Ikezoe T, Yang Y, Heber D, et al. PC-SPES: a potent inhibitor of nuclear factor-kappa B rescues mice from lipopolysaccharide-induced septic shock [J]. Mol Pharmacol, 2003; 64(6)∶1521.
|
4. |
O’Reilly M, Newcomb DE, Remick D. Endotoxin, sepsis, and the primrose path [J]. Shock, 1999; 12(6)∶411.
|
5. |
邵陽, 王翔. 膿毒血癥的治療進展 [J]. 醫學綜述, 2002; 8(4)∶244.
|
6. |
Flammand FJ, Sibbald WJ, Girotti MJ, et al. Pentoxifylline does not prevent microvascular injury in normotensive, septic rats [J]. Crit Care Med, 1995; 23(1)∶119.
|
7. |
嚴文偉, 周總光, 陳友琴, 等. 急性水腫性胰腺炎大鼠胰腺微血流變化和環氧合酶-2的表達 [J]. 中華肝膽外科雜志, 2004; 10(4)∶252.
|
8. |
張馨, 余衛平. 內毒素損傷肝臟機制的研究進展 [J]. 國外醫學·消化系疾病分冊, 2002; 22(3)∶163.
|
9. |
Kumagai T, Kawamoto Y, Nakamura Y, et al. 4-hydroxy-2-nonenal, the end product of lipid peroxidation, is a specific inducer of cyclooxygenase-2 gene expression [J]. Biochem Biophys Res Commun, 2000; 273(2)∶437.
|
10. |
Keller SA, Paxian M, Lee SM, et al. Kupffer cell ablation attenuates cyclooxygenase-2 expression after trauma and sepsis [J]. J Surg Res, 2005; 124(1)∶126.
|
11. |
李磊, 王興鵬. 膿毒癥的發病機制及其治療策略新認識 [J]. 國外醫學·生理、病理科學與臨床分冊, 2003; 23(6)∶650.
|
12. |
Frost RA, Nystrom GJ, Lang CH. Lipopolysaccharide regulates proinflammatory cytokine expression in mouse myoblasts and skeletal muscle [J]. Am J Physiol Regul Integr Comp Physiol, 2002; 283(3)∶R698.
|
13. |
Wang P, Li N, Li JS, et al. The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity [J]. World J Gastroenterol, 2002; 8(3)∶531.
|
14. |
Remick DG, Call DR, Ebong SJ, et al. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality [J]. Crit Care Med, 2001; 29(3)∶473.
|
15. |
程南生. 膿毒癥與感染性休克的免疫治療 [J]. 中國普外基礎與臨床雜志, 2004; 11(3)∶276.
|
16. |
Berg DJ, Zhang J, Lauricella DM, et al. IL-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production [J]. J Immunol, 2001; 166(4)∶2674.
|
17. |
Strong VE, Mackrell PJ, Concannon EM, et al. Blocking prostaglandin E2 after trauma attenuates pro-inflammatory cytokines and improves survival [J]. Shock, 2000; 14(3)∶374.
|
18. |
Callejas NA, Fernández-Martínez A, Castrillo A, et al. Selective inhibitors of cyclooxygenase-2 delay the activation of nuclear factor kappa B and attenuate the expression of inflammatory genes in murine macrophages treated with lipopolysaccharide [J]. Mol Pharmacol, 2003; 63(3)∶671.
|
19. |
林洪遠, 盛志勇. 膿毒癥免疫調理治療的新思路 [J]. 中國危重病急救醫學, 2004; 16(2)∶67.
|
20. |
蔣力生, 陳鵬. 膿毒癥與內毒素血癥的治療現狀與展望 [J]. 中國普外基礎與臨床雜志, 2004; 11(6)∶551.
|
21. |
Takeeda M, Yamato M, Kato S, et al. Cyclooxygenase iso-zymes involved in adaptive functional responses in rat stomach after barrier disruption [J]. J Pharmacol Exp Ther, 2003; 307(2)∶713.
|